NCT04580342 is a Phase 2 clinical trial of oral Ivabradine in Hypotension, sponsored by Ahmed talaat ahmed aly.

Who is sponsoring NCT04580342?

NCT04580342 is sponsored by Ahmed talaat ahmed aly.

What drugs are being tested in NCT04580342?

Interventions in NCT04580342: oral Ivabradine, oral Propranolol.

What condition does NCT04580342 study?

NCT04580342 studies Hypotension.

Is NCT04580342 still recruiting?

NCT04580342 is currently status unknown. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT04580342

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery

Status unknown Phase 2 Last updated 14 October 2020

What this trial tests

Phase 2 trial testing oral Ivabradine in Hypotension in 60 participants. Status unknown.

Timeline

15 October 2020

Primary endpoint
1 January 2021

30 January 2021

Quick facts

Lead sponsor	Ahmed talaat ahmed aly
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	15 October 2020
Primary completion	1 January 2021
Estimated completion	30 January 2021
Sites	1 location across Egypt

Drugs / interventions tested

oral Ivabradine
oral Propranolol — full drug profile →

Conditions studied

Hypotension — all drugs for Hypotension →

Sponsor

Ahmed talaat ahmed aly — full company profile →

Who can join

Adults 18 to 60, any sex, with Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study is designed to compare the effect of addition of oral Ivabradine, propranolol to general anesthesia aimed reduction in blood loss during functional endoscopic sinus surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypotension

Currently open trials in the same condition.

NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
NCT07494955 — "Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section" · NA · recruiting
NCT07481851 — Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients · recruiting
NCT06994494 — Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS · recruiting
NCT06953193 — Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia · NA · recruiting

Other Ahmed talaat ahmed aly trials

Trials by the same sponsor.

NCT04580329 — The Effect of Neuromuscular Electrical Stimulation (NMES) on the Renal Function and Renal Blood Flow · NA · unknown
NCT04586790 — the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock · Phase 2 · unknown
NCT04576221 — Comparative Study Between CPAP Mask and Stacked Breathing o Pneumonia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04580342 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed talaat ahmed aly
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04580342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing